---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-202204"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:56:00.574917+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ResMed appoints Christopher DelOrefice to board of directors, effective August 15, 2024

## Summary
- DelOrefice is EVP and CFO of Becton Dickinson, brings 30+ years of audit, finance and strategic expertise.
- Board expanded to 11 members; DelOrefice will serve on audit committee.
- Appointment effective immediately; will stand for re-election at Nov 21, 2024 annual meeting.
- DelOrefice previously served as VP Investor Relations at Johnson & Johnson and CFO of North America Hospital Medical Devices.

## SEC filing metadata
- accession: 0001193125-24-202204
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/0001193125-24-202204-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/d885393d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-202204
- JSON: https://secwatch.observer/filing/0001193125-24-202204.json
- Plain text: https://secwatch.observer/filing/0001193125-24-202204.txt

## Key facts
- Executive change
  Christopher DelOrefice was appointed as Director at RESMED INC.
  - Action: appointed
  - Role: Director
  source text: On August 15, 2024, ResMed Inc. appointed Christopher DelOrefice to serve on its board of directors, with a term expiring at ResMed’s 2024 annual meeting of stockholders on November 21, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/0001193125-24-202204-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.